{"id":867466,"date":"2025-07-08T09:38:00","date_gmt":"2025-07-08T13:38:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/"},"modified":"2025-07-08T09:38:00","modified_gmt":"2025-07-08T13:38:00","slug":"alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/","title":{"rendered":"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval"},"content":{"rendered":"<p>        <!--.bwlistdecimal { list-style-type: decimal }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Combined vitreoretinal-cataract system (VCS) is cleared for use in Canada<\/b><\/li>\n<li><b>New, proprietary technology is designed to deliver significant surgical and workflow efficiencies<\/b><\/li>\n<li><b>First innovation to be introduced from Alcon\u2019s cutting-edge Unity portfolio of surgical equipment<\/b><\/li>\n<\/ul>\n<p>TORONTO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAlcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY<sup>\u00ae<\/sup> Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon\u2019s highly anticipated Unity portfolio.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250708893871\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250708893871\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/4\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg\" alt=\"UNITY\u00ae Vitreoretinal Cataract System (VCS)\" \/><\/p>\n<p style=\"font-size:85%\">UNITY\u00ae Vitreoretinal Cataract System (VCS)<\/p>\n<\/div>\n<p>\n\u201cToday marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who helped us reach this milestone,\u201d said Franck Leveiller, Head of Global R&amp;D and Chief Scientific Officer, Alcon. \u201cWe have a long legacy of engaging our customers throughout the research and development process to design bold innovations in ophthalmology. This approval is a significant milestone in delivering meaningful impact for Canadian Eye Care Professionals and patients.\u201d<\/p>\n<p>\nUnity VCS is Alcon&#8217;s most advanced vitreoretinal and cataract surgical innovations combined together in one integrated platform. Unity VCS is designed to deliver enhanced workflow efficiencies over Alcon\u2019s current leading systems, CONSTELLATION<sup>\u00ae<\/sup> Vision System for vitreoretinal and combined procedures, and CENTURION<sup>\u00ae<\/sup> Vision System with ACTIVE SENTRY<sup>\u00ae<\/sup> for cataract surgery.<\/p>\n<p>\n&#8220;The first time I used Unity VCS in a wet lab environment, I had a real &#8216;wow&#8217; reaction,&#8221; said Dr. Rosa Braga-Mele, ophthalmologist and chair of Alcon\u2019s North America Cataract Core Advisory Board. &#8220;This is a proud moment to see the world-class innovation from Alcon receive approval in Canada. I&#8217;m particularly excited about the stability of the fluidics and cutting efficiency of the platform, which is quite remarkable and will create considerable surgical efficiencies.&#8221;<\/p>\n<p>\nUnity VCS leverages a novel phacoemulsification modality to deliver up to two times faster nucleus removal<sup>^ <\/sup>with 40% less energy<sup>*<\/sup> into the eye<sup>1<\/sup>, and a first-of-its-kind phaco handpiece that estimates temperature at the incision site<sup>3<\/sup>. In vitreoretinal advancements, the new technology offers cutting speeds of up to 30,000 cuts per minute, the world\u2019s fastest vitrectomy probe<sup>#,2,3<\/sup>.<sup \/>The platform offers surgical stability and efficiency with a unique proprietary fluidics system<sup>3<\/sup>.<\/p>\n<p>\n&#8220;As a global market leader in cataract and retina surgical products<sup>4,5,6<\/sup>, Alcon recognizes that the increasing demand for these procedures<sup>7,8,9 <\/sup>necessitates<sup \/>enhanced workflow efficiencies and excellent patient outcomes,&#8221; said Jeroen Bastemeijer, General Manager, Alcon Canada. &#8220;Unity VCS builds on Alcon\u2019s expertise in surgical equipment with pioneering innovations for vitreoretinal and cataract surgery\u2014driving advancements from cutting speeds to fluidics management, to ergonomics and workflow. We are thrilled to bring this latest breakthrough technology, Unity VCS, to Canadian clinics in 2026.&#8221;<\/p>\n<p>\nAlcon has tested Unity VCS during investigational advisory wet lab sessions with more than 200 highly experienced surgeons from 30+ countries. Commercial launch of Unity VCS is expected in early 2026.<\/p>\n<p>\nUnity VCS is the latest innovation from the Alcon Vision Suite\u2014a portfolio of innovative products designed to help Eye Care Professionals increase clinic and OR efficiency, and deliver exceptional patient experiences. The Alcon Vision Suite will continue to grow with cutting-edge Unity products that are expected to be introduced over the coming years, adding to our market-leading legacy products, which will continue to be available and serviceable. Unity VCS will be supported by Alcon\u2019s training, product maintenance, and Services teams.<\/p>\n<p><b><span class=\"bwuline\">About Alcon<br \/>\n<br \/><\/span><\/b>Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people\u2019s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.alcon.ca&amp;esheet=54287062&amp;newsitemid=20250708893871&amp;lan=en-US&amp;anchor=www.alcon.ca&amp;index=1&amp;md5=8d6b954e989dadc8a96ae968a3853e0f\">www.alcon.ca<\/a>.<\/p>\n<p><b><span class=\"bwuline\">About UNITY VCS<br \/>\n<br \/><\/span><\/b><b>Indications \/ Intended Use<sup>3<\/sup>:<\/b> The <b>UNITY<sup>\u00ae<\/sup> VCS<\/b> (Vitreoretinal Cataract System) console, when used with compatible devices, is indicated for use during anterior segment (i.e. phacoemulsification and removal of cataracts) and posterior segment (i.e. vitreoretinal) ophthalmic surgery. In addition, with the optional laser, this system is indicated for photocoagulation (i.e. vitreoretinal and macular pathologies), iridotomy and trabeculoplasty procedures.<\/p>\n<p><i>Please refer to the Directions for Use for the accessories\/consumables and User Manual for a complete listing of indications, warnings, cautions and notes.<\/i><\/p>\n<p>\n^2x faster nucleus removal than OZIL Torsional phaco<br \/>\n<br \/>*Based on N=10 HPs, Artificial cataract lens IOP 55 mmHg vacuum of 450 mmHg<br \/>\n<br \/><sup>#<\/sup>Compared to Constellation HYPERVIT 20k vitrectomy probe<br \/>\n<br \/><i>OZIL &#8211; Trademarks are the property of their respective owners.<\/i><\/p>\n<p><b><span class=\"bwuline\">References<\/span><\/b><\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nAlcon Data on File, 2024 &#8211; REF-24379.<\/p>\n<\/li>\n<li>\nAlcon Data on File, 2024 &#8211; REF-24644.<\/p>\n<\/li>\n<li>\nUnity VCS User Manual 2024 \u2013 REF-24980.<\/p>\n<\/li>\n<li>\nMarket Scope 2023 Retinal Surgical Device Market Report, 2023.<\/p>\n<\/li>\n<li>\nMarket Scope 2023 Cataract Surgical Equipment Market Report, 2023.<\/p>\n<\/li>\n<li>\nMarket Scope 2024 IOL Market Report, 2024.<\/p>\n<\/li>\n<li>\nCNIB \u2013 Blindness in Canada, Accessed December 2, 2024 &#8211; REF-19527.<\/p>\n<\/li>\n<li>\nThe Prevalence of Canadian Vision Loss and Cataract Surgery, 2019 &#8211; REF-01661.<\/p>\n<\/li>\n<li>\nConference Board of Canada &#8211; Ophthalmology in Canada: Why Vision Loss Should Not Be Overlooked, 2020 &#8211; REF-10834.<\/p>\n<\/li>\n<\/ol>\n<p><b>Connect with us on<br \/>\n<br \/><\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FAlconEyeCare%2F&amp;esheet=54287062&amp;newsitemid=20250708893871&amp;lan=en-US&amp;anchor=Facebook&amp;index=2&amp;md5=6b3bc6cfd40bb534a612bca06d9a3a01\">Facebook<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Falcon&amp;esheet=54287062&amp;newsitemid=20250708893871&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=4d276cd5324dd855b8c6831d9c7440de\">LinkedIn<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250708893871r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250708893871\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250708893871\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Media Relations<br \/>\n<\/span><\/b><br \/>Jane Lee Cheung<br \/>\n<br \/>+1 289 290 2393 (Canada)<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:jane.leecheung@alcon.com\">jane.leecheung@alcon.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> General Health Surgery Other Health Health Optical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/3\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">UNITY\u00ae Vitreoretinal Cataract System (VCS)<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517067\/3\/Alcon_RGB_Tag.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval Combined vitreoretinal-cataract system (VCS) is cleared for use in Canada New, proprietary technology is designed to deliver significant surgical and workflow efficiencies First innovation to be introduced from Alcon\u2019s cutting-edge Unity portfolio of surgical equipment TORONTO&#8211;(BUSINESS WIRE)&#8211; Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY\u00ae Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon\u2019s highly anticipated Unity portfolio. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250708893871\/en\/ UNITY\u00ae Vitreoretinal Cataract System (VCS) \u201cToday marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-867466","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval Combined vitreoretinal-cataract system (VCS) is cleared for use in Canada New, proprietary technology is designed to deliver significant surgical and workflow efficiencies First innovation to be introduced from Alcon\u2019s cutting-edge Unity portfolio of surgical equipment TORONTO&#8211;(BUSINESS WIRE)&#8211; Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY\u00ae Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon\u2019s highly anticipated Unity portfolio. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250708893871\/en\/ UNITY\u00ae Vitreoretinal Cataract System (VCS) \u201cToday marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment &hellip; Continue reading &quot;Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-08T13:38:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/4\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval\",\"datePublished\":\"2025-07-08T13:38:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/\"},\"wordCount\":939,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708893871\\\/en\\\/2517069\\\/4\\\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/\",\"name\":\"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708893871\\\/en\\\/2517069\\\/4\\\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg\",\"datePublished\":\"2025-07-08T13:38:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708893871\\\/en\\\/2517069\\\/4\\\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708893871\\\/en\\\/2517069\\\/4\\\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/","og_locale":"en_US","og_type":"article","og_title":"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Market Newsdesk","og_description":"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval Combined vitreoretinal-cataract system (VCS) is cleared for use in Canada New, proprietary technology is designed to deliver significant surgical and workflow efficiencies First innovation to be introduced from Alcon\u2019s cutting-edge Unity portfolio of surgical equipment TORONTO&#8211;(BUSINESS WIRE)&#8211; Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY\u00ae Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon\u2019s highly anticipated Unity portfolio. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250708893871\/en\/ UNITY\u00ae Vitreoretinal Cataract System (VCS) \u201cToday marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment &hellip; Continue reading \"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-08T13:38:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/4\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval","datePublished":"2025-07-08T13:38:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/"},"wordCount":939,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/4\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/","name":"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/4\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg","datePublished":"2025-07-08T13:38:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/4\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250708893871\/en\/2517069\/4\/AC7695_Unityvcs-product-visuals_1by1-blue_07-07-2025_RM.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alcons-latest-breakthrough-surgical-technology-unity-vcs-receives-health-canada-approval\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alcon\u2019s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=867466"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867466\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=867466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=867466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=867466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}